Zimmer Holdings has introduced new injectable pain relief gel, Gel-One Hyaluronate, for knee arthritis patients who failed to respond to non-pharmacologic therapy, non-steroidal anti-inflammatory drugs or analgesics.
The low-volume viscosupplement product was approved as a pain reliever that improves knee joint function in a single injection.
Zimmer senior vice president David Nolan said, "Gel-One Hyaluronate is a supplement to natural synovial fluid, offering pain relief to patients living with knee osteoarthritis. We are excited to introduce this joint preservation technology to surgeons and their patients in the United States."
A 3ml highly purified Gel-One Hyaluronate is enough for the safe and effective treatment, according to the company.
Increased viscoelasticity of Gel-One Hyaluronate is due to the manufacturing procedure that used cross-linking process.
